July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Hagop Kantarjian: Dasatinib and Venetoclax is safe and effective in newly diagnosed CML in CP
Apr 20, 2024, 07:03

Hagop Kantarjian: Dasatinib and Venetoclax is safe and effective in newly diagnosed CML in CP

Hagop Kantarjian, Professor and Chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center, shared a post on X:

Dasatinib and Venetoclax is safe and effective in newly diagnosed Chronic Myeloid Leukaemia in CP, but no better than single-agent Dasatinib, longer follow-up needed to evaluate impact on TFR.”

Hagop Kantarjian: Dasatinib and Venetoclax is safe and effective in newly diagnosed CML in CP

Additional information.
Source: Hagop Kantarjian/X